Pondering vexing issues in infection prevention and control
Thursday, June 24, 2010
We're good enough, we're smart enough, and doggone it, people like us!
Today's daily affirmation for infectious diseases doctors comes to us from Dave Warren's group at Washington University and is published in this month's American Journal of Medicine. In this study, the authors evaluated 341 cases of Staph. aureus bacteremia and compared outcomes between those patients who had an infectious diseases consult and those who didn't. Not at all surprising to any of us was that in multivariable analysis, patients who had ID consults had a 56% reduction in 28-day all-cause mortality, even though by most metrics the patients who had the consults were sicker. So when you start your rounds tomorrow consider yourself an independent predictor of good outcomes!
Subscribe to:
Post Comments (Atom)
OSHA! OSHA! OSHA!
In many parts of the country, as rates of COVID-19 are declining and vaccination coverage is increasing (albeit with substantial variati...
-
In many parts of the country, as rates of COVID-19 are declining and vaccination coverage is increasing (albeit with substantial variati...
-
This is a guest post by Jorge Salinas, MD, Hospital Epidemiologist at the University of Iowa Hospitals & Clinics. There is virtually no...
-
I’m surprised that we can’t stop arguing about the modes of SARS-CoV-2 transmission, despite the fact that most experts (including our frie...
Thanks for posting on this, Mike.
ReplyDeleteSimilar findings in this recently published study from Germany:
http://www.ncbi.nlm.nih.gov/pubmed/19654021
This begs a question: how far should we go to "encourage" ID consults in every case of S. aureus bacteremia? Should it be automatic? Should we add a text comment to the micro lab report, suggesting an ID consult and citing this literature?
Would we go to jail for self-referral?
ReplyDelete